Xingyu Gao, MPH

Senior Scientist, RWE Analytics
Genesis Research Group

Poster(s):

• (66) Analysis on the net costs of administering a prior authorization policy for onabotulinumtoxinA in the chronic migraine population
  Wednesday, October 29, 2025